<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">76766</article-id><article-id pub-id-type="doi">10.7554/eLife.76766</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Structural Biology and Molecular Biophysics</subject></subj-group></article-categories><title-group><article-title>Crystal structures of bacterial small multidrug resistance transporter EmrE in complex with structurally diverse substrates</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-168694"><name><surname>Kermani</surname><given-names>Ali A</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-266508"><name><surname>Burata</surname><given-names>Olive E</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8450-8930</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-235490"><name><surname>Koff</surname><given-names>B Ben</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-3276-143X</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-199739"><name><surname>Koide</surname><given-names>Akiko</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-199740"><name><surname>Koide</surname><given-names>Shohei</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf3"/></contrib><contrib contrib-type="author" corresp="yes" id="author-165878"><name><surname>Stockbridge</surname><given-names>Randy B</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-8848-3032</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf4"/></contrib><aff id="aff1"><institution content-type="dept">Department of Molecular, Cellular and Developmental Biology</institution>, <institution>University of Michigan</institution>, <addr-line><named-content content-type="city">Ann Arbor</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><institution content-type="dept">Laura and Isaac Perlmutter Cancer Center</institution>, <institution>New York University Langone Medical Center</institution>, <addr-line><named-content content-type="city">New York</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-15000"><name><surname>Ben-Tal</surname><given-names>Nir</given-names></name><role>Reviewing editor</role><aff><institution>Tel Aviv University</institution>, <country>Israel</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>stockbr@umich.edu</email> (RS);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>07</day><month>03</month><year>2022</year></pub-date><volume>11</volume><elocation-id>e76766</elocation-id><history><date date-type="received"><day>04</day><month>01</month><year>2022</year></date><date date-type="accepted"><day>06</day><month>03</month><year>2022</year></date></history><permissions><copyright-statement>© 2022, Kermani et al</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Kermani et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-76766-v1.pdf"/><abstract><p>Proteins from the bacterial small multidrug resistance (SMR) family are proton-coupled exporters of diverse antiseptics and antimicrobials, including polyaromatic cations and quaternary ammonium compounds. The transport mechanism of the <italic>Escherichia coli</italic> transporter, EmrE, has been studied extensively, but a lack of high-resolution structural information has impeded a structural description of its molecular mechanism. Here we apply a novel approach, multipurpose crystallization chaperones, to solve several structures of EmrE, including a 2.9 Å structure at low pH without substrate. We report five additional structures in complex with structurally diverse transported substrates, including quaternary phosphonium, quaternary ammonium, and planar polyaromatic compounds. These structures show that binding site tryptophan and glutamate residues adopt different rotamers to conform to disparate structures without requiring major rearrangements of the backbone structure. Structural and functional comparison to Gdx-Clo, an SMR protein that transports a much narrower spectrum of substrates, suggests that in EmrE, a relatively sparse hydrogen bond network among binding site residues permits increased sidechain flexibility.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd><italic>E. coli</italic></kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>CA194864</award-id><principal-award-recipient><name><surname>Koide</surname><given-names>Shohei</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000001</institution-id><institution>National Science Foundation</institution></institution-wrap></funding-source><award-id>CAREER 1845012</award-id><principal-award-recipient><name><surname>Stockbridge</surname><given-names>Randy B</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Akiko Koide, is listed as inventor for patents (US9512199 B2 and related patents and applications) covering aspects of the monobody technology filed by the University of Chicago and Novartis..</p></fn><fn fn-type="conflict" id="conf3"><p>Shohei Koide, is listed as inventor for patents (US9512199 B2 and related patents and applications) covering aspects of the monobody technology filed by the University of Chicago and Novartis. Is a scientific advisory board member and holds equity in and receives consulting fees from Black Diamond Therapeutics; receives research funding from Puretech Health and Argenx BVBA..</p></fn><fn fn-type="conflict" id="conf4"><p>Randy B Stockbridge, Reviewing editor, <italic>eLife</italic>.</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>Atomic coordinates for the crystal structures have been deposited in the Protein Data Bank under accession numbers 7MH6 (EmrE3/L10), 7MGX (EmrE3/L10/methyl viologen), 7SVX (EmrE3/L10/harmane), 7SSU (EmrE3/L10/MeTPP+), 7SV9 (EmrE3/L10/TPP+), 7T00 (EmrE3/L10/benzyltrimethylammonium) and 7SZT (Gdx-Clo/L10). All other data generated or analyzed during this study are included in the manuscript and supporting file; Source Data files have been provided for Figures 1 and 5.</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Kermani AA</collab><collab>Stockbridge RB</collab></person-group><year iso-8601-date="2022">2022</year><source>Structure of EmrE-D3 mutant in complex with monobody L10 in low pH (protonated state)</source><ext-link ext-link-type="uri" xlink:href="https://www.rcsb.org/structure/7MH6">https://www.rcsb.org/structure/7MH6</ext-link><comment>Protein Data Bank, 7MH6</comment></element-citation><element-citation id="dataset2" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Kermani AA</collab><collab>Stockbridge RB</collab></person-group><year iso-8601-date="2022">2022</year><source>Structure of EmrE-D3 mutant in complex with monobody L10 and methyl viologen</source><ext-link ext-link-type="uri" xlink:href="https://www.rcsb.org/structure/7MGX">https://www.rcsb.org/structure/7MGX</ext-link><comment>Protein Data Bank, 7MGX</comment></element-citation><element-citation id="dataset3" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Kermani AA</collab><collab>Stockbridge RB</collab></person-group><year iso-8601-date="2022">2022</year><source>Structure of EmrE-D3 mutant in complex with monobody L10 and harmane</source><ext-link ext-link-type="uri" xlink:href="https://www.rcsb.org/structure/7SVX">https://www.rcsb.org/structure/7SVX</ext-link><comment>Protein Data Bank, 7SVX</comment></element-citation><element-citation id="dataset4" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Kermani AA</collab><collab>Stockbridge RB</collab></person-group><year iso-8601-date="2022">2022</year><source>Structure of EmrE-D3 mutant in complex with monobody L10 and methyltriphenylphosphonium</source><ext-link ext-link-type="uri" xlink:href="https://www.rcsb.org/structure/7SSU">https://www.rcsb.org/structure/7SSU</ext-link><comment>Protein Data Bank, 7SSU</comment></element-citation><element-citation id="dataset5" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Kermani AA</collab><collab>Stockbridge RB</collab></person-group><year iso-8601-date="2022">2022</year><source>Structure of EmrE-D3 mutant in complex with monobody L10 and TPP</source><ext-link ext-link-type="uri" xlink:href="https://www.rcsb.org/structure/7SV9">https://www.rcsb.org/structure/7SV9</ext-link><comment>Protein Data Bank, 7SV9</comment></element-citation><element-citation id="dataset6" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Kermani AA</collab><collab>Stockbridge RB</collab></person-group><year iso-8601-date="2022">2022</year><source>Structure of EmrE-D3 mutant in complex with monobody L10 and benzyltrimethylammonium</source><ext-link ext-link-type="uri" xlink:href="https://www.rcsb.org/structure/7T00">https://www.rcsb.org/structure/7T00</ext-link><comment>Protein Data Bank, 7T00</comment></element-citation><element-citation id="dataset7" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Kermani AA</collab><collab>Stockbridge RB</collab><collab>Burata OE</collab></person-group><year iso-8601-date="2022">2022</year><source>https://www.rcsb.org/structure/7SZT</source><ext-link ext-link-type="uri" xlink:href="https://www.rcsb.org/structure/7SZT">https://www.rcsb.org/structure/7SZT</ext-link><comment>Protein Data Bank, 7SZT</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-76766-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>